Monohydrate lisinopril
US6468976B1 · kind B1 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 2001 |
| Grant date | Oct 22, 2002 |
| Priority date | — |
| Expiry date | Sep 10, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel monohydrate form of 1-(N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl)-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel monohydrate form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel monohydrate form of lisinopril.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.